Literature DB >> 14977164

Volterra series in pharmacokinetics and pharmacodynamics.

Davide Verotta1.   

Abstract

Nonparametric black-box modeling has a long successful history of applications in pharmacokinetics (PK) (notably in deconvolution), but is rarely used in pharmacodynamics (PD). The main reason is associated with the fact that PK systems are often linear in respect to drug inputs, while the reverse is true for many PK/PD systems. In the PK/PD field existing non-parametric methods can deal with linear systems, but they cannot describe non-linear systems. Our purpose is to describe a novel implementation of a general nonparametric model which can represent non-linear systems, and in particular non-linear PK/PD systems, The model is based on a Volterra series, which is an integral series expansion of the response of a system in terms of its kernels and the inputs to the system. In PK we are familiar with the first term of the Volterra series, the convolution of the first kernel of the system (the so-called PK disposition function) with drug input rates. The main advantages of higher order Volterra representations is that they are general representations and can be used to describe and predict the response of an arbitrary (PK/ PD) system without any prior knowledge on the structure of the system. The main problem of the representation is that in a non-parametric representation of the kernels the number of parameters to be estimated grows geometrically with the order of the kernel. We developed a method to estimate the kernels in a Volterra-series which overcomes this problem. The method (i) is fully non-parametric (the kernels are represented using multivariate splines), (ii) is maximum-likelihood based, (iii) is adaptive (the order of the series and the dimensionality of each kernel is selected by the method), and (iv) allows for non-equispaced observations (thus allowing a reduction of the number of parameters in the representation, and the analysis of, e.g., PK/PD observations). The method is based on an adaptation of Friedmans's Multivariate Adaptive Regression Spline method. Examples demonstrate the possible application of the approach to the analysis of different PK/PD systems.

Entities:  

Mesh:

Year:  2003        PMID: 14977164     DOI: 10.1023/b:jopa.0000008158.30235.59

Source DB:  PubMed          Journal:  J Pharmacokinet Pharmacodyn        ISSN: 1567-567X            Impact factor:   2.745


  12 in total

1.  Linear mixed-effect multivariate adaptive regression splines applied to nonlinear pharmacokinetics data.

Authors:  J M Gries; D Verotta
Journal:  J Biopharm Stat       Date:  2000-08       Impact factor: 1.051

2.  Theoretical and computational basis for drug bioavailability determinations using pharmacological data. II. Drug input in equilibrium to response relationships.

Authors:  V F Smolen
Journal:  J Pharmacokinet Biopharm       Date:  1976-08

3.  A general framework for non-parametric subject-specific and population deconvolution methods for in vivo-in vitro correlation.

Authors:  D Verotta
Journal:  Adv Exp Med Biol       Date:  1997       Impact factor: 2.622

Review 4.  Concepts, properties, and applications of linear systems to describe distribution, identify input, and control endogenous substances and drugs in biological systems.

Authors:  D Verotta
Journal:  Crit Rev Biomed Eng       Date:  1996

5.  The maximum likelihood approach to the identification of neuronal firing systems.

Authors:  D R Brillinger
Journal:  Ann Biomed Eng       Date:  1988       Impact factor: 3.934

6.  Kinetics of interaction between drugs and biological systems.

Authors:  G Segre
Journal:  Farmaco Sci       Date:  1968-10

7.  A general conceptual model for non-steady state pharmacokinetic/pharmacodynamic data.

Authors:  D Verotta; L B Sheiner
Journal:  J Pharmacokinet Biopharm       Date:  1995-02

8.  Identification of nonlinear biological systems using Laguerre expansions of kernels.

Authors:  V Z Marmarelis
Journal:  Ann Biomed Eng       Date:  1993 Nov-Dec       Impact factor: 3.934

9.  Estimation and model selection in constrained deconvolution.

Authors:  D Verotta
Journal:  Ann Biomed Eng       Date:  1993 Nov-Dec       Impact factor: 3.934

10.  Physiologic indirect response models characterize diverse types of pharmacodynamic effects.

Authors:  W J Jusko; H C Ko
Journal:  Clin Pharmacol Ther       Date:  1994-10       Impact factor: 6.875

View more
  2 in total

Review 1.  Pharmacokinetic-pharmacodynamic modelling: history and perspectives.

Authors:  Chantal Csajka; Davide Verotta
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-01-11       Impact factor: 2.745

2.  Use of in vitro-in vivo correlation to predict the pharmacokinetics of several products containing a BCS class 1 drug in extended release matrices.

Authors:  Tahseen Mirza; Srikant A Bykadi; Christopher D Ellison; Yongsheng Yang; Barbara M Davit; Mansoor A Khan
Journal:  Pharm Res       Date:  2012-08-22       Impact factor: 4.200

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.